Home>Judiciary>Perdue Pharma set to plead guilty in N.J. on Tuesday

Perdue Pharma set to plead guilty in N.J. on Tuesday

By David Wildstein, November 23 2020 4:04 pm

A major drug manufacturer is set to admit guilt in the abuse of prescription opioids in an appearance before a federal judge in New Jersey on Tuesday.

Purdue Pharma is expected to acknowledge their role in conspiracies to defraud the United States as well as violations of the Food, Drug and Cosmetic Act and the federal Anti-Kickback law, the U.S. Attorney’s office in Newark announced today.

The Justice Department announced a global resolution last month into criminal and civil investigations into Purdue.

Part of their corporate plea agreement includes admitted that they marketed opioid products to more than 100 health care providers despite information that they were diverting the painkiller and reporting false information to the Drug Enforcement Administration.

“The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths, in addition to those caused by illicit street opioids,” Deputy Attorney General Jeffrey Rosen said in October. “With criminal guilty pleas, a federal settlement of more than $8 billion, and the dissolution of a company and repurposing its assets entirely for the public’s benefit, the resolution in today’s announcement re-affirms that the Department of Justice will not relent in its multi-pronged efforts to combat the opioids crisis.”

The company will appear by videoconference before U.S. District Court Judge Madeline Cox Arleo in response to an information that charges them with three counts of conspiracy.

Spread the news: